Neurontin and Methylphenidate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Neurontin (gabapentin) and Methylphenidate (methylphenidate). Common drug interactions include eosinophil count increased among females and suicidal ideation among males.
The phase IV clinical study analyzes what interactions people have when they take Neurontin and Methylphenidate. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
What is Methylphenidate?
Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.
74 people who take Neurontin and Methylphenidate together, and have interactions are studied.

What are the common drug interactions of Neurontin and Methylphenidate, by gender? *:
female:
- Eosinophil count increased
- Eye disorder
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Foot fracture
- Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Glaucoma (increased fluid pressure in the eye with vision loss)
- Haematocrit increased
- Head injury
- Hypertension (high blood pressure)
male:
- Suicidal ideation
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Surgery
- Weight increased
- Diarrhoea
- Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
- Abnormal sleep-related event
- Anxiety
- Bone density decreased
- Cataplexy (loss of muscle tone accompanied by full conscious awareness)
What are the common drug interactions of Neurontin and Methylphenidate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Cerebral haemorrhage (bleeding within the brain)
- Headache (pain in head)
- Hypersomnia (excessive daytime sleepiness (eds))
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Pyrexia (fever)
- Vomiting
20-29:
n/a
30-39:
- Depression
- Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
- Suicidal ideation
- Bone density decreased
- Cough
- Dyspnoea (difficult or laboured respiration)
- Emotional distress
- Fatigue (feeling of tiredness)
- Foot fracture
- Hand fracture
40-49:
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Surgery
50-59:
- Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
- Adrenal adenoma (benign tumour of the glandular type (adenoma) in the adrenal gland)
- Adrenal cyst (cysts of the adrenal gland)
- Attention deficit hyperactivity disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness)
- Depression
- Drug hypersensitivity
- Expanded disability status scale score increased
- Fall
- Hospitalisation
- Kidney infection
60+:
- Dizziness
- Diarrhoea
- Blood phosphorus decreased
- Blood thyroid stimulating hormone decreased
- Blood thyroid stimulating hormone increased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cough
- Dry mouth
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 44 people, 59.46%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 35 people, 47.30%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 12 people, 16.22%
- Pain: 5 people, 6.76%
- Drowsiness: 5 people, 6.76%
* Approximation only. Some reports may have incomplete information.
Do you take Neurontin and Methylphenidate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Neurontin (107,468 reports)
- Methylphenidate (8,216 reports)
Browse all drug interactions of Neurontin and Methylphenidate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Methylphenidate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neurontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylphenidate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and methylphenidate (the active ingredients of Neurontin and Methylphenidate, respectively), and Neurontin and Methylphenidate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Calcium Carbonate and Ditropan - now
- Drug interactions of Benadryl and Imbruvica - a second ago
- Blood Cholesterol Decreased and Cataract - a second ago
- Drug interactions of Dexchlorpheniramine Maleate and Ondansetron Hydrochloride - 3 seconds ago
- Could Ativan cause Dysphoria? - 10 seconds ago
- Could Mavik cause Itching? - 16 seconds ago
- Could Hydrocortisone Sodium Succinate cause Confusion Aggravated? - 17 seconds ago
- Could Perphenazine cause Dizziness Aggravated? - 22 seconds ago
- Could Miacalcin cause White Blood Cell Count Decreased? - 30 seconds ago
- Could Methotrexate Sodium cause Thyroxine Decreased? - 34 seconds ago